1. Home
  2. GAUZ vs ONCY Comparison

GAUZ vs ONCY Comparison

Compare GAUZ & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • ONCY
  • Stock Information
  • Founded
  • GAUZ 2009
  • ONCY 1998
  • Country
  • GAUZ Israel
  • ONCY Canada
  • Employees
  • GAUZ N/A
  • ONCY N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • GAUZ Miscellaneous
  • ONCY Health Care
  • Exchange
  • GAUZ Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • GAUZ 102.0M
  • ONCY 106.1M
  • IPO Year
  • GAUZ 2024
  • ONCY 1999
  • Fundamental
  • Price
  • GAUZ $2.12
  • ONCY $1.05
  • Analyst Decision
  • GAUZ Strong Buy
  • ONCY Strong Buy
  • Analyst Count
  • GAUZ 2
  • ONCY 6
  • Target Price
  • GAUZ $11.50
  • ONCY $6.00
  • AVG Volume (30 Days)
  • GAUZ 218.9K
  • ONCY 750.7K
  • Earning Date
  • GAUZ 11-13-2025
  • ONCY 11-12-2025
  • Dividend Yield
  • GAUZ N/A
  • ONCY N/A
  • EPS Growth
  • GAUZ N/A
  • ONCY N/A
  • EPS
  • GAUZ N/A
  • ONCY N/A
  • Revenue
  • GAUZ $96,810,000.00
  • ONCY N/A
  • Revenue This Year
  • GAUZ $22.59
  • ONCY N/A
  • Revenue Next Year
  • GAUZ $41.48
  • ONCY N/A
  • P/E Ratio
  • GAUZ N/A
  • ONCY N/A
  • Revenue Growth
  • GAUZ 7.87
  • ONCY N/A
  • 52 Week Low
  • GAUZ $1.52
  • ONCY $0.33
  • 52 Week High
  • GAUZ $13.00
  • ONCY $1.51
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ 27.36
  • ONCY 44.10
  • Support Level
  • GAUZ $1.52
  • ONCY $0.97
  • Resistance Level
  • GAUZ $2.17
  • ONCY $1.15
  • Average True Range (ATR)
  • GAUZ 0.48
  • ONCY 0.06
  • MACD
  • GAUZ -0.14
  • ONCY 0.00
  • Stochastic Oscillator
  • GAUZ 14.85
  • ONCY 36.11

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: